DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 18:53:47 14/06/2024 BST | ||
| 162.4 EUR | +0.39% |
|
| Current month | +2.51% | ||
| 1 month | +2.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 162.4 | +0.39% |
| 13/06/24 | 161.8 | +1.16% |
| 12/06/24 | 160 | -0.53% |
| 11/06/24 | 160.8 | +0.25% |
| 10/06/24 | 160.4 | +0.40% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 06:53 pm
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VD0QCQ |
| ISIN | DE000VD0QCQ7 |
| Date issued | 21/02/2024 |
| Maturity | 20/12/2024 (188 Days) |
| Parity | 1 : 1 |
| Emission price | 158.7 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 162.7 € |
|---|---|
| Lowest since issue | 152.6 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat